ATE312909T1 - Diagnostika und behandlungen von peridontalen erkrankungen - Google Patents
Diagnostika und behandlungen von peridontalen erkrankungenInfo
- Publication number
- ATE312909T1 ATE312909T1 AT96934198T AT96934198T ATE312909T1 AT E312909 T1 ATE312909 T1 AT E312909T1 AT 96934198 T AT96934198 T AT 96934198T AT 96934198 T AT96934198 T AT 96934198T AT E312909 T1 ATE312909 T1 AT E312909T1
- Authority
- AT
- Austria
- Prior art keywords
- complex
- prtr
- prtk
- multimeric
- gingivalis
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 241000605862 Porphyromonas gingivalis Species 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 239000004475 Arginine Substances 0.000 abstract 1
- 102000005593 Endopeptidases Human genes 0.000 abstract 1
- 108010059378 Endopeptidases Proteins 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 230000005875 antibody response Effects 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 229940066758 endopeptidases Drugs 0.000 abstract 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56955—Bacteria involved in periodontal diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN6275A AUPN627595A0 (en) | 1995-10-30 | 1995-10-30 | Diagnostics and treatments of periodontal disease |
| PCT/AU1996/000673 WO1997016542A1 (en) | 1995-10-30 | 1996-10-30 | Diagnostics and treatments of periodontal disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312909T1 true ATE312909T1 (de) | 2005-12-15 |
Family
ID=3790602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96934198T ATE312909T1 (de) | 1995-10-30 | 1996-10-30 | Diagnostika und behandlungen von peridontalen erkrankungen |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6511666B1 (de) |
| EP (1) | EP0858504B1 (de) |
| JP (1) | JP4117026B2 (de) |
| KR (1) | KR100286055B1 (de) |
| AT (1) | ATE312909T1 (de) |
| AU (2) | AUPN627595A0 (de) |
| DE (1) | DE69635582T2 (de) |
| DK (1) | DK0858504T3 (de) |
| ES (1) | ES2255082T3 (de) |
| NZ (1) | NZ320015A (de) |
| WO (1) | WO1997016542A1 (de) |
| ZA (1) | ZA969130B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0735293U (ja) * | 1993-12-10 | 1995-06-27 | 株式会社松島製作所 | もやいの照明装置 |
| AUPN627595A0 (en) * | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| US20030157637A1 (en) * | 1998-09-15 | 2003-08-21 | The University Of Melbourne | Diagnostics and treatments of periodontal disease |
| AUPO652897A0 (en) * | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
| US8129500B2 (en) | 1997-12-10 | 2012-03-06 | Csl Limited | Porphyromonas gingivalis polypeptides and nucleotides |
| EP2283855A3 (de) * | 1997-12-10 | 2011-05-04 | CSL Limited | Polypeptide und Nukleinsäuren von Phorphorymonas gingivalis |
| AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
| AUPP893999A0 (en) * | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| AUPQ718200A0 (en) * | 2000-04-28 | 2000-05-25 | Csl Limited | Porphyromonas gingivalis recombinant proteins and truncations |
| SE0400191D0 (sv) * | 2004-01-30 | 2004-01-30 | Tendera Ab | A test kit for detecting periodontal disease |
| AU2005287884B2 (en) * | 2004-09-23 | 2010-12-02 | The University Of Melbourne | Antigenic complex for the diagnosis and treatment of Porphyromonas gingivalis infection |
| JP5154935B2 (ja) * | 2004-09-23 | 2013-02-27 | ザ・ユニヴァーシティ・オブ・メルボーン | Ｐｏｒｐｈｙｒｏｍｏｎａｓｇｉｎｇｉｖａｌｉｓ感染を診断および治療するための抗原複合体 |
| PL1971865T3 (pl) | 2006-01-10 | 2014-02-28 | Colgate Palmolive Co | Sposoby modulowania powierzchniowych receptorów komórek w celu zapobiegania zapaleniu lub jego zmniejszania |
| US20100092471A1 (en) | 2006-06-27 | 2010-04-15 | Oral Health Australia Pty Ltd | Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease |
| US20100297179A1 (en) * | 2007-07-12 | 2010-11-25 | Stuart Geoffrey Dashper | Immunology Treatment for Biofilms |
| US8241611B2 (en) | 2007-07-12 | 2012-08-14 | Oral Health Austrailia Pty. Ltd. | Biofilm treatment |
| NZ591612A (en) * | 2008-08-29 | 2012-08-31 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of p.gingivalis infection with peptides |
| US8140041B2 (en) * | 2009-08-27 | 2012-03-20 | Mediatek Inc. | Tunable capacitive device with linearization technique employed therein |
| MY162557A (en) | 2010-02-26 | 2017-06-15 | Oral Health Australia Pty Ltd | Treatment or prevention of infection |
| MA50363A (fr) | 2017-10-12 | 2020-08-19 | Vaxcyte Inc | Vaccin contre la parodontite et compositions associées et procédé d'utilisation |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830710A (en) | 1988-09-08 | 1998-11-03 | University Of Florida | Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| WO1995000110A1 (fr) * | 1993-06-28 | 1995-01-05 | Lion Corporation | Composition pour la cavite buccale |
| US5475097A (en) * | 1993-10-21 | 1995-12-12 | University Of Georgia Research Foundation, Inc. | Lysine-specific Porphyromonas gingivalis proteinase |
| EP0717747B1 (de) * | 1993-09-10 | 2003-06-04 | The University Of Georgia Research Foundation, Inc. | Porphyromonas gingivalis arginin-spezifische proteinase kodierende sequenzen |
| US5523390A (en) * | 1993-09-10 | 1996-06-04 | University Of Georgia Research Foundation, Inc. | Porphyromonas gingivalis arginine-specific proteinase |
| AUPN627595A0 (en) * | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| AUPO652897A0 (en) * | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
-
1995
- 1995-10-30 AU AUPN6275A patent/AUPN627595A0/en not_active Abandoned
-
1996
- 1996-10-30 EP EP96934198A patent/EP0858504B1/de not_active Expired - Lifetime
- 1996-10-30 KR KR1019980703117A patent/KR100286055B1/ko not_active IP Right Cessation
- 1996-10-30 ES ES96934198T patent/ES2255082T3/es not_active Expired - Lifetime
- 1996-10-30 AU AU72673/96A patent/AU715456B2/en not_active Ceased
- 1996-10-30 ZA ZA969130A patent/ZA969130B/xx unknown
- 1996-10-30 WO PCT/AU1996/000673 patent/WO1997016542A1/en active IP Right Grant
- 1996-10-30 AT AT96934198T patent/ATE312909T1/de active
- 1996-10-30 DE DE69635582T patent/DE69635582T2/de not_active Expired - Lifetime
- 1996-10-30 JP JP51691597A patent/JP4117026B2/ja not_active Expired - Fee Related
- 1996-10-30 NZ NZ320015A patent/NZ320015A/xx not_active IP Right Cessation
- 1996-10-30 DK DK96934198T patent/DK0858504T3/da active
- 1996-10-30 US US09/066,330 patent/US6511666B1/en not_active Expired - Lifetime
-
2007
- 2007-01-18 US US11/654,512 patent/US20070189982A1/en not_active Abandoned
-
2011
- 2011-03-16 US US13/064,286 patent/US20110213129A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR100286055B1 (ko) | 2001-05-02 |
| ES2255082T3 (es) | 2006-06-16 |
| US20110213129A1 (en) | 2011-09-01 |
| AU715456B2 (en) | 2000-02-03 |
| ZA969130B (en) | 1997-06-24 |
| EP0858504A4 (de) | 2002-12-04 |
| DE69635582D1 (de) | 2006-01-19 |
| KR19990067167A (ko) | 1999-08-16 |
| NZ320015A (en) | 1999-02-25 |
| WO1997016542A1 (en) | 1997-05-09 |
| EP0858504A1 (de) | 1998-08-19 |
| AU7267396A (en) | 1997-05-22 |
| DK0858504T3 (da) | 2006-02-13 |
| JP2000510817A (ja) | 2000-08-22 |
| JP4117026B2 (ja) | 2008-07-09 |
| US6511666B1 (en) | 2003-01-28 |
| DE69635582T2 (de) | 2006-08-17 |
| AUPN627595A0 (en) | 1995-11-23 |
| EP0858504B1 (de) | 2005-12-14 |
| US20070189982A1 (en) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE312909T1 (de) | Diagnostika und behandlungen von peridontalen erkrankungen | |
| CY1110128T1 (el) | Καταλυτικα μονοκλωνικα αντισωματα με δραστικοτητα πρωτεασης για την εκλεκτικη λυση του πρωτεϊνικου συστατικου των πλακων και συνονθυλευματων που σχετιζονται με παθολογικες καταστασεις | |
| ES2074042T3 (es) | Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores. | |
| TR199902124T2 (xx) | �ltihapl� hastal�klar�n tedavisinde yararl� k���k molek�ller. | |
| ATE257390T1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
| DE69526216D1 (de) | Antifungaleverfahren und mitteln | |
| ATE202706T1 (de) | Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom | |
| ATE203895T1 (de) | Reinigungsemulsionen | |
| ATE226442T1 (de) | Anti-chlamydia verfahren und mittel | |
| ATE510851T1 (de) | Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose | |
| ES2216055T3 (es) | Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob. | |
| ATE198050T1 (de) | Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia | |
| DE69410254T2 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
| DE69434223D1 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
| ATE234111T1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| ATE240743T1 (de) | Verfahren und substanzen gegen protozoen | |
| DK0584343T3 (da) | Rekombinant alkalisk phosphatase fra kalvetarme | |
| EE05497B1 (et) | Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha | |
| NO974322D0 (no) | DNA som koder for human papillomvirus type 18 | |
| DE69433243D1 (de) | Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit | |
| PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
| ITRM920506A1 (it) | Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi. | |
| DK1040191T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
| KR910006478A (ko) | 인체 트립타제 유사 단백질 | |
| ATE312914T1 (de) | Rdgb-proteine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0858504 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |